Showing results (1-10 of 344) with videos related to
Sort By:
Pageof 35
Expert Opinion on Pharmacotherapy|March 12, 2004
The use of TNF-alpha blocking agents in rheumatoid arthritis: an overviewEric Toussirot, Daniel WendlingExpert Opinion on Pharmacotherapy|January 9, 2003
Recent progress in ankylosing spondylitis treatmentEric Toussirot, Daniel WendlingCurrent Opinion in Rheumatology|June 7, 2007
Antiinflammatory treatment with bisphosphonates in ankylosing spondylitisEric Toussirot, Daniel WendlingExpert Opinion on Pharmacotherapy|February 16, 2005
Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathiesEric Toussirot, Daniel WendlingDrugs & Aging|June 25, 2005
Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment optionsEric Toussirot, Daniel WendlingExpert Opinion on Pharmacotherapy|June 24, 2004
Anti-TNF-alpha therapy in ankylosing spondylitisDaniel Wendling, Eric ToussirotExpert Opinion on Pharmacotherapy|August 24, 2007
The use of TNF-alpha blocking agents in rheumatoid arthritis: an updateEric Toussirot, Daniel WendlingRecent Patents on Inflammation & Allergy Drug Discovery|December 17, 2008
Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a reviewEric Toussirot, Gérald Streit, Daniel WendlingCurrent Medicinal Chemistry|April 26, 2007
The contribution of adipose tissue and adipokines to inflammation in joint diseasesEric Toussirot, Gérald Streit, Daniel WendlingJoint Bone Spine|October 27, 2006
Imaging study scores for ankylosing spondylitisDaniel Wendling, Eric Toussirot, Gérald Streit, et al.Pageof 35